Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A renal cell carcinoma tumorgraft platform to advance precision medicine.
Elias R, Tcheuyap VT, Kaushik AK, Singla N, Gao M, Reig Torras O, Christie A, Mulgaonkar A, Woolford L, Stevens C, Kettimuthu KP, Pavia-Jimenez A, Boroughs LK, Joyce A, Dakanali M, Notgrass H, Margulis V, Cadeddu JA, Pedrosa I, Williams NS, Sun X, DeBerardinis RJ, Öz OK, Zhong H, Seshagiri S, Modrusan Z, Cantarel BL, Kapur P, Brugarolas J. Elias R, et al. Among authors: mulgaonkar a. Cell Rep. 2021 Nov 23;37(8):110055. doi: 10.1016/j.celrep.2021.110055. Cell Rep. 2021. PMID: 34818533 Free PMC article.
PD-L1 detection using 89Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response.
Vento J, Mulgaonkar A, Woolford L, Nham K, Christie A, Bagrodia A, de Leon AD, Hannan R, Bowman I, McKay RM, Kapur P, Hao G, Sun X, Brugarolas J. Vento J, et al. Among authors: mulgaonkar a. J Immunother Cancer. 2019 Jun 3;7(1):144. doi: 10.1186/s40425-019-0607-z. J Immunother Cancer. 2019. PMID: 31155004 Free PMC article.
Gliomas Interact with Non-glioma Brain Cells via Extracellular Vesicles.
Gao X, Zhang Z, Mashimo T, Shen B, Nyagilo J, Wang H, Wang Y, Liu Z, Mulgaonkar A, Hu XL, Piccirillo SGM, Eskiocak U, Davé DP, Qin S, Yang Y, Sun X, Fu YX, Zong H, Sun W, Bachoo RM, Ge WP. Gao X, et al. Among authors: mulgaonkar a. Cell Rep. 2020 Feb 25;30(8):2489-2500.e5. doi: 10.1016/j.celrep.2020.01.089. Cell Rep. 2020. PMID: 32101730 Free article.
Radiolabeling strategies and pharmacokinetic studies for metal based nanotheranostics.
Ranjbar Bahadori S, Mulgaonkar A, Hart R, Wu CY, Zhang D, Pillai A, Hao Y, Sun X. Ranjbar Bahadori S, et al. Among authors: mulgaonkar a. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Mar;13(2):e1671. doi: 10.1002/wnan.1671. Epub 2020 Oct 12. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021. PMID: 33047504 Review.
Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy.
Mulgaonkar A, Udayakumar D, Yang Y, Harris S, Öz OK, Ramakrishnan Geethakumari P, Sun X. Mulgaonkar A, et al. Front Med (Lausanne). 2023 Jun 27;10:1199146. doi: 10.3389/fmed.2023.1199146. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37441689 Free PMC article. Review.
PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression.
Tang H, Liang Y, Anders RA, Taube JM, Qiu X, Mulgaonkar A, Liu X, Harrington SM, Guo J, Xin Y, Xiong Y, Nham K, Silvers W, Hao G, Sun X, Chen M, Hannan R, Qiao J, Dong H, Peng H, Fu YX. Tang H, et al. Among authors: mulgaonkar a. J Clin Invest. 2018 Feb 1;128(2):580-588. doi: 10.1172/JCI96061. Epub 2018 Jan 16. J Clin Invest. 2018. PMID: 29337303 Free PMC article.
33 results